课题基金 / 基金详情

Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock: A Phase II RCT

Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock: A Phase II RCT
脐带间充质基质细胞作为感染性休克的细胞免疫疗法:II 期随机对照试验
批准号:
474604
负责人:
McIntyre Lauralyn A
金额:
$24.02万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
未结题
起止时间:
2022-07-01 至 2025-07-01

项目摘要

项目成果

McIntyre Lauralyn A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Severe infection with shock (septic shock) in the intensive care unit (ICU) accounts for approximately 20% of admissions, of which 20 to 40% will die. Septic shock is associated with an uncontrolled inflammatory response that is initiated by an infectious
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock: A Phase II RCT
  • 批准号:
    466352
  • 项目类别:
    Operating Grants
  • 资助金额:
    $96.07万
  • 财政年份:
    2022
  • 负责人:
    McIntyre Lauralyn A
  • 依托单位:
Crystalloid FLUID Choices for Resuscitation of Hospitalized Patients: A Pragmatic Comparative Effectiveness Trial (FLUID)
  • 批准号:
    380648
  • 项目类别:
    Operating Grants
  • 资助金额:
    $27.31万
  • 财政年份:
    2018
  • 负责人:
    McIntyre Lauralyn A
  • 依托单位:
Cellular Immunotherapy in Septic Shock: A Meeting to Develop a Stem Cell in Sepsis International Collaborative Network
  • 批准号:
    372833
  • 项目类别:
    Miscellaneous Programs
  • 资助金额:
    $0.73万
  • 财政年份:
    2017
  • 负责人:
    McIntyre Lauralyn A
  • 依托单位:
Cellular Immunotherapy for Septic Shock (CISS): A Phase II Trial
  • 批准号:
    366625
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2016
  • 负责人:
    McIntyre Lauralyn A
  • 依托单位:
海外基金